Skip to main content
  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
Logo image Logo image
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline (Opens in a new tab/window)
      • PBM Guidelines (Opens in a new tab/window)
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines (Opens in a new tab/window)
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Search

  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline
      • PBM Guidelines
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Australian Bleeding Disorders Registry

  • Home
  • Clinical guidance
  • Australian Bleeding Disorders Registry

The Australian Bleeding Disorders Registry (ABDR) is a database used to collect information on bleeding disorders.

It includes information like:

  • patient diagnosis
  • treatment details
  • hospital admissions and administrative information
  • details on ordering, supply and use of clotting factor products.

Haemophilia Treatment Centre (HTC) staff use the ABDR to:

  • manage how they treat bleeding disorders in patients
  • understand bleeding disorder rates in Australia.
     

Accessing the ABDR

Access the ABDR through BloodPortal(Opens in a new tab/window).

If you work in a HTC and you don't have access yet, take these steps:

  1. Talk to your HTC director about whether you should have access.
  2. Create a BloodPortal account.
  3. Select the ABDR icon in BloodPortal to request access.
  4. Complete and submit the online form.

You'll get an email about the outcome of your application.

Patients can record data for the ABDR in the MyABDR app or website.

Adding a new patient to the ABDR

You should register patients who:

  • have a bleeding disorder that is in the scope of the ABDR
  • you're treating with a product that is funded under the national blood arrangements.

Bleeding disorders in scope are:

  • haemophilia A and B (including with inhibitors)
  • other factor deficiencies, including fibrinogen
  • von Willebrand’s disease (vWD)
  • platelet dysfunction
  • acquired factor VIII inhibitor
     
  • some vascular disorders.

The products that are funded are detailed on the National Product Price List.

Steps to register a new patient

Add new patients the first time they visit your clinic. At this first meeting, talk about the need to take the patient's information.

Registering a patient will not change your ability to manage their treatment.

  1. Talk to the patient about registration and get verbal consent – use our verbal consent script as a guide.
     
  2. Fill out the ABDR patient registration PDF form.
  3. Make sure you fill out anything marked with an asterisk –¬†this is mandatory information.
  4. Fax or email the completed form to your nearest HTC.
     

Find your nearest HTC(Opens in a new tab/window) through the Australian Haemophilia Centre Directors' Organisation website.

  • ABDR patient registration form
    354.92 KB

Patient privacy consent

Obtain the patient's consent before adding their information.

  • Give patients a copy of the ABDR consent leaflet to help them understand consent.
  • Record consent using either our consent form or recording verbal agreement, including over the phone.
  • Record the patient's consent status in the patient's ABDR profile.
  • ABDR MyABDR Privacy Collection Notice and Consent Form
    186 KB
  • ABDRMyABDR Privacy Collection Notice and Consent Form with Pseudonyms
    186 KB
  • ABDR verbal privacy consent script and form
    86.32 KB
  • Privacy consenting for HTCs ‚– ABDR tip sheet
    146.66 KB

Adding patient minimum information

You can enter a patient's information, or they can do it through the MyABDR app after you've created a record.

You must provide this information:

  • Full name and address details – so one unique record is created for each patient across Australia
  • Date of birth – to calculate age cohorts
  • Gender
  • Diagnosis
  • Severity
  • Baseline factor level and date where relevant – this doesn't apply for vWD or platelet disorders, but is needed to assess international standards on severity classification
  • Weight – to help understand dosing for clotting factors
  • Treatment regimen – the product used, dosing and frequency of treatment; for example, add a comment if a patient's condition is mild and only treated on demand
  • Attending physician and clinic/hospital – for follow-up and contact where needed

Giving this minimum amount of information helps with:

  • creating ABDR patient identification cards
  • accurate statistics on bleeding disorders
  • supply planning
  • estimating demand and forecasting
  • future planning discussions about product ordering processes.

ABDR management

We administer and provide support to the ABDR and MyABDR app.

Managing information privacy

We collect and manage all patient information in line with:

  • the Privacy Act 1988 (Cth)(Opens in a new tab/window)
  • other rules under state and territory laws.

A patient must give their consent before their data is recorded. Read our full privacy policy.

  • ABDR MyABDR Privacy Collection Notice and Consent Form (Footer includes Date Approved 23 May 2024_0 (1)_1.pdf
    186 KB

Using ABDR data

Data in the ABDR helps us understand the demand for blood products. All patient information is de-identified.

We use this information to:

  • manage blood product supply arrangements
  • estimate product demand in the future.
     

Governance

To keep the ABDR up to date, we work with:

  • Australian Haemophilia Centre Directors' Organisation (AHCDO)(Opens in a new tab/window)
  • Haemophilia Foundation Australia(Opens in a new tab/window).

Read more about ABDR and MyABDR governance arrangements: 

  • ABDR-myabdr-governance-arrangements.pdf
    261.54 KB
  • ABDR-myabdr-governance-arrangements.docx
    1.09 MB

Annual reports

We publish these reports on outcomes of the ABDR each year. 

Get in touch

For ABDR support, contact the Blood Operations Centre 24 hours a day, 7 days a week.

  • Phone: 13 000 25663 (13 000 BLOOD)

For other enquiries email support@blood.gov.au.

Last updated: 27 Mar 2024

Back to top

The National Blood Authority acknowledges the Traditional Owners and Custodians of Country throughout Australia, and their continuing connection to land, water and community. We pay our respects to the people, the cultures and the elders past, present and emerging.

National Blood Authority

  • About the NBA
  • Work with us
  • Contact Us
  • Data and reporting
  • Freedom of information
  • Public interest disclosure
  • Resources
  • Accessibility
  • Privacy
  • Copyright
  • Disclaimer
  • BloodPortal Terms and Conditions of Use

Information

  • Blood Products
  • Managing blood supply
  • Supply systems
  • Clinical guidance
  • Patient information
  • Data and research
  • Website feedback